233 related articles for article (PubMed ID: 24189063)
1. CD154 is released from T-cells by a disintegrin and metalloproteinase domain-containing protein 10 (ADAM10) and ADAM17 in a CD40 protein-dependent manner.
Yacoub D; Benslimane N; Al-Zoobi L; Hassan G; Nadiri A; Mourad W
J Biol Chem; 2013 Dec; 288(50):36083-93. PubMed ID: 24189063
[TBL] [Abstract][Full Text] [Related]
2. CD154 Resistant to Cleavage from Intracellular Milieu and Cell Surface Induces More Potent CD40-Mediated Responses.
Salti S; Al-Zoobi L; Darif Y; Hassan GS; Mourad W
J Immunol; 2021 Apr; 206(8):1793-1805. PubMed ID: 33762325
[TBL] [Abstract][Full Text] [Related]
3. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
Ebsen H; Schröder A; Kabelitz D; Janssen O
PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
[TBL] [Abstract][Full Text] [Related]
4. Membrane-anchored CD40 is processed by the tumor necrosis factor-alpha-converting enzyme. Implications for CD40 signaling.
Contin C; Pitard V; Itai T; Nagata S; Moreau JF; Déchanet-Merville J
J Biol Chem; 2003 Aug; 278(35):32801-9. PubMed ID: 12810728
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
Ebsen H; Lettau M; Kabelitz D; Janssen O
Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
[TBL] [Abstract][Full Text] [Related]
6. The transmembrane CXC-chemokine ligand 16 is induced by IFN-gamma and TNF-alpha and shed by the activity of the disintegrin-like metalloproteinase ADAM10.
Abel S; Hundhausen C; Mentlein R; Schulte A; Berkhout TA; Broadway N; Hartmann D; Sedlacek R; Dietrich S; Muetze B; Schuster B; Kallen KJ; Saftig P; Rose-John S; Ludwig A
J Immunol; 2004 May; 172(10):6362-72. PubMed ID: 15128827
[TBL] [Abstract][Full Text] [Related]
7. CD154 inhibits death of T cells via a Cis interaction with the α5β1 integrin.
Bachsais M; Salti S; Zaoui K; Hassan GS; Aoudjit F; Mourad W
PLoS One; 2020; 15(8):e0235753. PubMed ID: 32745080
[TBL] [Abstract][Full Text] [Related]
8. Proteolytically active ADAM10 and ADAM17 carried on membrane microvesicles in human abdominal aortic aneurysms.
Folkesson M; Li C; Frebelius S; Swedenborg J; Wågsäter D; Williams KJ; Eriksson P; Roy J; Liu ML
Thromb Haemost; 2015 Nov; 114(6):1165-74. PubMed ID: 26422658
[TBL] [Abstract][Full Text] [Related]
9. Selective use of ADAM10 and ADAM17 in activation of Notch1 signaling.
Bozkulak EC; Weinmaster G
Mol Cell Biol; 2009 Nov; 29(21):5679-95. PubMed ID: 19704010
[TBL] [Abstract][Full Text] [Related]
10. Role of ADAM10 and ADAM17 in CD16b shedding mediated by different stimulators.
Guo S; Peng M; Zhao Q; Zhang W
Chin Med Sci J; 2012 Jun; 27(2):73-9. PubMed ID: 22770404
[TBL] [Abstract][Full Text] [Related]
11. Shedding of endogenous MHC class I-related chain molecules A and B from different human tumor entities: heterogeneous involvement of the "a disintegrin and metalloproteases" 10 and 17.
Chitadze G; Lettau M; Bhat J; Wesch D; Steinle A; Fürst D; Mytilineos J; Kalthoff H; Janssen O; Oberg HH; Kabelitz D
Int J Cancer; 2013 Oct; 133(7):1557-66. PubMed ID: 23526433
[TBL] [Abstract][Full Text] [Related]
12. The isolated N-terminal domains of TIMP-1 and TIMP-3 are insufficient for ADAM10 inhibition.
Rapti M; Atkinson SJ; Lee MH; Trim A; Moss M; Murphy G
Biochem J; 2008 Apr; 411(2):433-9. PubMed ID: 18215140
[TBL] [Abstract][Full Text] [Related]
13. ADAM10 regulates endothelial permeability and T-Cell transmigration by proteolysis of vascular endothelial cadherin.
Schulz B; Pruessmeyer J; Maretzky T; Ludwig A; Blobel CP; Saftig P; Reiss K
Circ Res; 2008 May; 102(10):1192-201. PubMed ID: 18420943
[TBL] [Abstract][Full Text] [Related]
14. Functional interaction of CD154 protein with α5β1 integrin is totally independent from its binding to αIIbβ3 integrin and CD40 molecules.
El Fakhry Y; Alturaihi H; Yacoub D; Liu L; Guo W; Leveillé C; Jung D; Khzam LB; Merhi Y; Wilkins JA; Li H; Mourad W
J Biol Chem; 2012 May; 287(22):18055-66. PubMed ID: 22461623
[TBL] [Abstract][Full Text] [Related]
15. Minimal interleukin 6 (IL-6) receptor stalk composition for IL-6 receptor shedding and IL-6 classic signaling.
Baran P; Nitz R; Grötzinger J; Scheller J; Garbers C
J Biol Chem; 2013 May; 288(21):14756-68. PubMed ID: 23564454
[TBL] [Abstract][Full Text] [Related]
16. The good, the bad and the ugly substrates for ADAM10 and ADAM17 in brain pathology, inflammation and cancer.
Pruessmeyer J; Ludwig A
Semin Cell Dev Biol; 2009 Apr; 20(2):164-74. PubMed ID: 18951988
[TBL] [Abstract][Full Text] [Related]
17. Role of ADAM10 and ADAM17 in Regulating CD137 Function.
Seidel J; Leitzke S; Ahrens B; Sperrhacke M; Bhakdi S; Reiss K
Int J Mol Sci; 2021 Mar; 22(5):. PubMed ID: 33800462
[TBL] [Abstract][Full Text] [Related]
18. Soluble T cell immunoglobulin and mucin domain (TIM)-1 and -4 generated by A Disintegrin And Metalloprotease (ADAM)-10 and -17 bind to phosphatidylserine.
Schweigert O; Dewitz C; Möller-Hackbarth K; Trad A; Garbers C; Rose-John S; Scheller J
Biochim Biophys Acta; 2014 Feb; 1843(2):275-87. PubMed ID: 24286866
[TBL] [Abstract][Full Text] [Related]
19. Surface expression and limited proteolysis of ADAM10 are increased by a dominant negative inhibitor of dynamin.
Carey RM; Blusztajn JK; Slack BE
BMC Cell Biol; 2011 May; 12():20. PubMed ID: 21586144
[TBL] [Abstract][Full Text] [Related]
20. Shedding of Endogenous Interleukin-6 Receptor (IL-6R) Is Governed by A Disintegrin and Metalloproteinase (ADAM) Proteases while a Full-length IL-6R Isoform Localizes to Circulating Microvesicles.
Schumacher N; Meyer D; Mauermann A; von der Heyde J; Wolf J; Schwarz J; Knittler K; Murphy G; Michalek M; Garbers C; Bartsch JW; Guo S; Schacher B; Eickholz P; Chalaris A; Rose-John S; Rabe B
J Biol Chem; 2015 Oct; 290(43):26059-71. PubMed ID: 26359498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
